Back to companies

Neuronetics, Inc.

STIMUSNASDAQPharmaceuticals & Healthcare

Neuronetics, Inc.

Revenue
$149.2mn
YoY +99.2%
Operating income
-$31.4mn
FY2025
Employees
—
Founded
—

Source: U.S. Securities and Exchange Commission (SEC) EDGAR Company Facts API